The Latest Headlines at Watch List News
Albany International Q2 Earnings Call Highlights
Albany International (NYSE:AIN) reported second-quarter revenue growth and its strongest adjusted EBITDA performance in two years, driven by higher production rates in its Engineered Composites business, while Machine Clothing faced... More of this article »
Fukuoka Financial Group (OTCMKTS:FKKFF) Sets New 52-Week High – Still a Buy?
Fukuoka Financial Group, Inc. (OTCMKTS:FKKFF – Get Free Report) hit a new 52-week high during trading on Tuesday . The company traded as high as $46.65 and last traded at $46.65, with a volume of 100 shares trading hands. The... More of this article »
John Hancock Multifactor Developed International ETF (NYSEARCA:JHMD) Reaches New 1-Year High – Here’s What Happened
John Hancock Multifactor Developed International ETF (NYSEARCA:JHMD – Get Free Report) reached a new 52-week high during trading on Tuesday . The stock traded as high as $46.04 and last traded at $46.03, with a volume of 20332... More of this article »
Alpha Architect U.S. Quantitative Value ETF (NASDAQ:QVAL) Hits New 1-Year High – What’s Next?
Alpha Architect U.S. Quantitative Value ETF (NASDAQ:QVAL – Get Free Report) hit a new 52-week high during trading on Tuesday . The company traded as high as $59.62 and last traded at $59.62, with a volume of 6915 shares changing... More of this article »
iShares MSCI ACWI ETF (NASDAQ:ACWI) Reaches New 12-Month High – Here’s Why
iShares MSCI ACWI ETF (NASDAQ:ACWI – Get Free Report) shares hit a new 52-week high on Tuesday . The company traded as high as $160.13 and last traded at $160.13, with a volume of 1373305 shares traded. The stock had previously... More of this article »
T. Rowe Price Dividend Growth ETF (NYSEARCA:TDVG) Reaches New 1-Year High – Here’s What Happened
Shares of T. Rowe Price Dividend Growth ETF (NYSEARCA:TDVG – Get Free Report) reached a new 52-week high during mid-day trading on Tuesday . The stock traded as high as $50.31 and last traded at $50.28, with a volume of 21077... More of this article »
SPDR S&P MidCap 400 ETF Trust (NYSEARCA:MDY) Hits New 52-Week High – Time to Buy?
SPDR S&P MidCap 400 ETF Trust (NYSEARCA:MDY – Get Free Report)’s stock price hit a new 52-week high during mid-day trading on Tuesday . The stock traded as high as $704.62 and last traded at $705.2180, with a volume... More of this article »
Sable Offshore (NYSE:SOC) Trading Down 5.7% – Here’s Why
Sable Offshore Corp. (NYSE:SOC – Get Free Report)’s share price was down 5.7% during trading on Tuesday . The company traded as low as $4.47 and last traded at $4.5450. 1,854,468 shares changed hands during trading, a decline... More of this article »
NioCorp Developments (NASDAQ:NB) Trading 15% Higher – Still a Buy?
Shares of NioCorp Developments Ltd. (NASDAQ:NB – Get Free Report) rose 15% on Tuesday . The company traded as high as $5.06 and last traded at $5.1290. 2,686,577 shares traded hands during trading, a decline of 39% from the average... More of this article »
China Mengniu Dairy (OTCMKTS:CIADY) Sees Unusually-High Trading Volume – Here’s Why
China Mengniu Dairy (OTCMKTS:CIADY – Get Free Report) shares saw strong trading volume on Tuesday . 27,722 shares were traded during mid-day trading, an increase of 227% from the previous session’s volume of 8,488 shares.The... More of this article »
iShares Core S&P U.S. Value ETF (NASDAQ:IUSV) Hits New 52-Week High – Here’s Why
iShares Core S&P U.S. Value ETF (NASDAQ:IUSV – Get Free Report)’s stock price reached a new 52-week high during trading on Tuesday . The company traded as high as $113.86 and last traded at $113.79, with a volume of... More of this article »
Jazz Pharmaceuticals (NASDAQ:JAZZ) Hits New 12-Month High on Analyst Upgrade
Jazz Pharmaceuticals PLC (NASDAQ:JAZZ – Get Free Report) reached a new 52-week high during mid-day trading on Tuesday after JPMorgan Chase & Co. raised their price target on the stock from $265.00 to $276.00. JPMorgan Chase... More of this article »
Research Analysts’ Weekly Ratings Updates for Prelude Therapeutics (PRLD)
Several analysts have recently updated their ratings and price targets for Prelude Therapeutics (NASDAQ: PRLD): 7/29/2026 – Prelude Therapeutics had its “sell (d-)” rating reaffirmed by Weiss Ratings. 7/29/2026 –... More of this article »